Research Paper Volume 15, Issue 22 pp 13265—13286
Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients
Figure 1. Increased KLRB1 levels were associated with diagnosis and better prognosis in BRCA using TCGA and K-M plotter databases. (A) KLRB1 expression in unpaired tissues; (B) KLRB1 expression in paired tissues; (C) The diagnostic effect of KLRB1 using ROC analysis; (D–F) The better prognosis related the KLRB1 overexpression in TCGA database by using K-M analysis; (G–I) Increased KLRB1 expression was associated with better OS, DMFS, and RFS of BRCA patients in K-M plotter database. Abbreviations: OS: overall survival; DMFS: distant metastasis-free survival; RFS: recurrence-free survival; ROC: Receiver operating characteristic; K-M: Kaplan-Meier.